Esperion Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Esperion Therapeutics Inc
TickerESPR
CIK #0001434868
CUSIP29664W105
SectorLife Sciences - Pharmaceutical Preparations
Address46701 Commerce Center Drive, Plymouth, MI 48170
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Esperion Therapeutics Inc 2014-07-15 Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001434868] 10-K
[0001434868] 10-Q
[0001434868] 3
[0001434868] 4
[0001434868] 5
[0001434868] 8-K
[0001434868] D
[0001434868] SC 13D
[0001434868] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Glazer Capital LLC Esperion Therapeutics Inc [2026-06-08] 0.0
Wasatch Advisors LP Esperion Therapeutics Inc [2026-04-22] 0.0
Two SEAS Capital LP Esperion Therapeutics Inc [2025-08-13] 0.0
BlackRock Inc Esperion Therapeutics Inc [2024-11-08] 7.3
BlackRock Inc Esperion Therapeutics Inc [2024-10-22] 7.3
Millennium Management LLC Esperion Therapeutics Inc [2024-06-12] 5.4
Two SEAS Capital LP Esperion Therapeutics Inc [2023-10-05] 7.4
Millennium Management LLC Esperion Therapeutics Inc [2023-08-29] 5.0
Millennium Management LLC Esperion Therapeutics Inc [2023-08-28] 4.9
Point72 Asset Management LP Esperion Therapeutics Inc [2023-04-05] 4.8
BlackRock Inc Esperion Therapeutics Inc [2023-02-07] 7.5
Millennium Management LLC Esperion Therapeutics Inc [2023-01-20] 4.9
Point72 Asset Management LP Esperion Therapeutics Inc [2022-08-23] 4.9
CVI Investments Inc Esperion Therapeutics Inc [2021-12-10] 0.9
Deep Track Capital LP Esperion Therapeutics Inc [2021-12-09] 0.99
Sabby Management LLC Esperion Therapeutics Inc [2021-12-09] 0.13
Flynn James E Esperion Therapeutics Inc [2021-12-07] 8.17
Platinum Investment Management Ltd Esperion Therapeutics Inc [2021-02-12] 0.0
State Street Corp Esperion Therapeutics Inc [2021-02-11] 9.05
Wasatch Advisors Inc Esperion Therapeutics Inc [2020-12-03] 13.8
Marshall Wace LLP Esperion Therapeutics Inc [2020-06-15] 5.5
State Street Corp Esperion Therapeutics Inc [2019-02-14] 5.6
Vanguard Group Inc Esperion Therapeutics Inc [2019-02-11] 6.33
Partner Fund Management LP Esperion Therapeutics Inc [2018-05-14] 0.2
Boxer Capital LLC Esperion Therapeutics Inc [2018-05-11] 0.0
Meditor Group Ltd Esperion Therapeutics Inc [2017-08-21] 8.2
Boxer Capital LLC Esperion Therapeutics Inc [2017-03-23] 0.0
BlackRock Inc Esperion Therapeutics Inc [2017-01-30] 5.6
Viking Global Investors LP Esperion Therapeutics Inc [2015-06-29] 5.9
Visium Asset Management LP Esperion Therapeutics Inc [2015-03-27] 5.5
FMR LLC Esperion Therapeutics Inc [2015-02-13] 0.0
Pentwater Capital Management LP Esperion Therapeutics Inc [2015-02-13] 7.22
Domain Parters VII L P Esperion Therapeutics Inc [2014-10-30] 13.3
Pfizer Inc Esperion Therapeutics Inc [2014-02-13] 9.0
Aisling Capital II LP Esperion Therapeutics Inc [2014-02-07] 13.8
Domain Parters VII L P Esperion Therapeutics Inc [2014-02-06] 13.9
Arboretum Investment Manager II LLC Esperion Therapeutics Inc [2013-12-18] 5.2
Alta Partners VIII LP Esperion Therapeutics Inc [2013-07-11] 14.5
Longitude Capital Partners LLC Esperion Therapeutics Inc [2013-07-11] 11.0
Form 3/4/5 Filer 2011 - 2026
Esperion Therapeutics Inc
Koenig Sheldon L
Halladay Benjamin
Looker Benjamin
Hoffman Robert
Carroll J Martin
Fischer Seth H Z
Thompson John Craig
Shepard Jay
Harlow John B Jr
Woody Tracy M
Vitullo Nicole
Rocamboli Stephen
Warren Eric
Foody Joanne M
Gotto Antonio M Jr MD D Phil
Fuhrman Alan
Berkowitz Jeffrey
Bartram Richard
Janney Daniel
McGovern Mark E
BB Biotech AG
Biotech Target N V
Hall Ashley
Mayleben Timothy M
Glickman Mark A
Braunstein Scott
Newton Roger S
Lalwani Narendra D
Lewis Joseph
Boxer Asset Management Inc
Boxer Capital LLC
Braslyn Ltd
Tuesday Thirteen Inc
Goldstein Dov A MD
Omenn Gilbert S
McGowan Mary
Shah Nimesh
Enright Patrick G
Aisling Capital Partners LP
Elms Steve
Aisling Capital II LP
Schiff Andrew N
Aisling Capital Partners LLC
Purcell Dennis J
Blair James C
Treu Jesse I
Schoemaker Kathleen K
Domain Parters VII L P
Dovey Brian H
Halak Brian K
Alta Partners VIII LP
Longitude Capital Associates LP
Longitude Venture Partners LP
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Alta Partners Management VIII LLC
Nohra Guy P
Champsi Farah
Rosenberg Noah L
DP VII Associates LP
Lange Louis G
Domain Associates
Ignelzi Troy A
Kamdar Kim P
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Looker Benjamin
Common Stock
2026-03-17 Sell 5,708 $2.70 15,412
Halladay Benjamin
Common Stock
2026-03-17 Sell 6,424 $2.71 17,409
Koenig Sheldon L
Common Stock
2026-03-17 Sell 25,578 $2.72 69,572
Halladay Benjamin
Stock Option (right to buy) · derivative
2026-03-13 Grant 221,270 $0.00
Looker Benjamin
Stock Option (right to buy) · derivative
2026-03-13 Grant 269,230 $0.00
Koenig Sheldon L
Common Stock
2026-03-13 Grant 723,760 $0.00
Koenig Sheldon L
Stock Option (right to buy) · derivative
2026-03-13 Grant 647,460 $0.00
Halladay Benjamin
Common Stock
2026-03-13 Grant 247,430 $0.00
Looker Benjamin
Common Stock
2026-03-13 Grant 300,840 $0.00
Looker Benjamin
Common Stock
2026-01-20 Sell 1,689 $2.88 4,864
Halladay Benjamin
Common Stock
2025-12-17 Sell 7,337 $3.67 26,927
Koenig Sheldon L
Common Stock
2025-12-17 Sell 48,244 $3.67 177,055
Looker Benjamin
Common Stock
2025-12-17 Sell 6,517 $3.67 23,917
Harlow John B Jr
Common Stock
2025-12-04 Grant 424,536 $0.00
Harlow John B Jr
Stock Option (right to buy) · derivative
2025-12-04 Grant 380,000 $0.00
Looker Benjamin
Common Stock
2025-10-17 Sell 1,248 $2.62 3,270
Common Stock
2025-09-17 Sell 6,267 $2.80 17,548
Common Stock
2025-09-17 Sell 28,427 $2.79 79,311
Common Stock
2025-09-17 Sell 7,046 $2.81 19,799
Halladay Benjamin
Common Stock
2025-07-17 Sell 11 $1.12 12
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 207 177,897,759
2025-12-31 202 156,162,923
2025-09-30 191 109,928,496
2025-06-30 162 99,495,578
2025-03-31 188 113,357,292
2024-12-31 194 128,910,605
2024-09-30 189 134,036,645
2024-06-30 183 142,982,929
2024-03-31 158 133,450,884
2023-12-31 136 77,914,930
2023-09-30 128 78,913,687
2023-06-30 129 75,828,564
Form 13F Holdings
Firm Period DFND Voting Shares
Trium Capital LLP [2026-06-30] SOLE 11,158,150 11,158,150
Wasatch Advisors LP [2026-06-30] SOLE 1,930,185 1,930,185
Equitec Proprietary Markets LLC [2026-06-30] SOLE 345,800 823,700
Eleva Capital SAS [2026-06-30] SOLE 0 183,047
ABC Arbitrage Sa [2026-06-30] OTR 0 42,553
CFS Investment Advisory Services LLC [2026-06-30] SOLE 0 24,551
Spire Wealth Management [2026-06-30] SOLE 0 17,767
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 0 12,321
Affinity Capital Advisors LLC [2026-06-30] SOLE 0 10,000
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 2,050 2,050
Fortitude Family Office LLC [2026-06-30] SOLE 243 243
City State Bank [2026-06-30] SOLE 200 200
Gamma Investing LLC [2026-06-30] DFND 141 141
FNY Investment Advisers LLC [2026-06-30] SOLE 110,000 109
IFP Advisors LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com